Explore more publications!
Djibouti Health Journal
Submit Press Release

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 10, 2025

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
September 10, 2025

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston

Indeterminate GlobeNewswire
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
September 10, 2025

BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.

Indeterminate GlobeNewswire
AAFA Bill to Require Allergen Labeling in Restaurants Passes in California
September 10, 2025

AAFA Bill to Require Allergen Labeling in Restaurants Passes in California

Indeterminate GlobeNewswire
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform
September 10, 2025

Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform

Indeterminate GlobeNewswire
Partnership between Corewell Health and Nudj Health drives progress in chronic condition management
September 10, 2025

Partnership between Corewell Health and Nudj Health drives progress in chronic condition management

Indeterminate GlobeNewswire
Johns Hopkins Health Plans Opens 2026 Grant Application Period
September 10, 2025

Johns Hopkins Health Plans Opens 2026 Grant Application Period

Indeterminate GlobeNewswire
Realize Medical and Canon USA Partner to Redefine Procedural Planning Through Spatial Computing with VR and Imaging Technology
September 10, 2025

Realize Medical and Canon USA Partner to Redefine Procedural Planning Through Spatial Computing with VR and Imaging Technology

Indeterminate GlobeNewswire
Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors
September 10, 2025

Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors

Indeterminate GlobeNewswire
Niederländische Plattform macht dermatologische Versorgung weltweit unmittelbar zugänglich
September 10, 2025

Niederländische Plattform macht dermatologische Versorgung weltweit unmittelbar zugänglich

Indeterminate GlobeNewswire
Une plateforme néerlandaise rend les soins dermatologiques instantanément accessibles dans le monde entier
September 10, 2025

Une plateforme néerlandaise rend les soins dermatologiques instantanément accessibles dans le monde entier

Indeterminate GlobeNewswire
Plataforma holandesa torna o atendimento dermatológico instantaneamente acessível em todo o mundo
September 10, 2025

Plataforma holandesa torna o atendimento dermatológico instantaneamente acessível em todo o mundo

Indeterminate GlobeNewswire
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program
September 10, 2025

NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program

Indeterminate GlobeNewswire
KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025
September 10, 2025

KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025

Indeterminate GlobeNewswire
Saudi Food and Drug Authority, AAMI Partner on Medtech Best Practices
September 10, 2025

Saudi Food and Drug Authority, AAMI Partner on Medtech Best Practices

Indeterminate GlobeNewswire
neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
September 10, 2025

neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression

Indeterminate GlobeNewswire
Eleos Launches Smarter Support for Group Therapy and SUD Care
September 10, 2025

Eleos Launches Smarter Support for Group Therapy and SUD Care

Indeterminate GlobeNewswire
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
September 10, 2025

NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer

Indeterminate GlobeNewswire
Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades
September 10, 2025

Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades

Indeterminate GlobeNewswire
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
September 10, 2025

Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms
September 10, 2025

Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions